Covered recipient · General Payments record
MINDY E PRAGER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018
$187.83
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $187.83 | 9 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $75.20 | 4 |
| Otsuka America Pharmaceutical, Inc. | $45.13 | 2 |
| Neurocrine BioSciences, Inc. | $27.66 | 1 |
| Vanda Pharmaceuticals Inc. | $25.42 | 1 |
| Lundbeck LLC | $14.42 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $187.83 | 9 |
Payment records · PY2018 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Lundbeck LLC | $14.42 | 02/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567807475 | CMS |
| Neurocrine Biosciences, Inc. | $27.66 | 05/24/2018 | Food and Beverage | Undisputed | 01/23/2026 | 604156269 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.10 | 04/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | 606645965 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.03 | 07/31/2018 | Food and Beverage | Undisputed | 01/23/2026 | 606645969 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.10 | 05/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 614014649 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.50 | 08/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | 613962353 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.43 | 09/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 613920151 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.17 | 10/05/2018 | Food and Beverage | Undisputed | 01/23/2026 | 614098255 | CMS |
| Vanda Pharmaceuticals Inc. | $25.42 | 01/26/2018 | Food and Beverage | Undisputed | 01/23/2026 | 612311313 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.